肾移植缺血再灌注损伤:肾小管上皮细胞的3条关键信号通路
本文聚焦肾移植围手术期缺血再灌注损伤(IRI),综述肾小管上皮细胞中Toll样受体、1-磷酸鞘氨醇受体和缺氧诱导因子3条关键信号通路的研究进展。文章阐述跨膜受体激活后经蛋白相互作用影响炎症基因表达与线粒体呼吸,并涉及与内皮及白细胞的交互,指出针对这些通路的抑制剂已完成I期试验、II期正在进行,有望转化改善移植结局。
要点
- 肾小管上皮细胞Toll样受体可被内外源性配体激活,启动IRI炎症信号。
- 1-磷酸鞘氨醇受体与缺氧诱导因子通路参与调控线粒体呼吸及微环境交互。
- 针对上述信号通路的抑制剂已进入早期临床试验,具备转化潜力。
核心结论
- 明确肾小管上皮细胞IRI相关信号级联有助于发现新型干预靶点,以减轻IRI并潜在改善移植结局。
主要发现
- 跨膜受体被外源和内源配体激活后,经序贯蛋白-蛋白相互作用将信号传至细胞核心生理机制。
- 信号效应包括上调促炎基因产物和调节线粒体呼吸。
- 通路间交叉对话在单细胞水平协调应答,并通过与内皮和循环白细胞的密切交互调节周围组织微环境。
临床怎么用
- 针对上述信号级联特定组分的抑制剂已完成I期临床试验、II期正在进行,提示围手术期IRI干预的转化方向。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Renal ischemia-reperfusion injury (IRI) is a significant clinical challenge faced by clinicians perioperatively in kidney transplantation. Recent work has demonstrated the key importance of transmembrane receptors in the injured tubular epithelial cell, most notably Toll-like receptors, activated by exogenous and endogenous ligands in response to external and internal stresses. Through sequential protein-protein interactions, the signal is relayed deep into the core physiological machinery of the cell, having numerous effects from upregulation of pro-inflammatory gene products through to modulating mitochondrial respiration. Inter-pathway cross talk facilitates a co-ordinated response at an individual cellular level, as well as modulating the surrounding tissue's microenvironment through close interactions with the endothelium and circulating leukocytes. Defining the underlying cellular cascades involved in IRI will assist the identification of novel interventional targets to attenuate IRI with the potential to improve transplantation outcomes. We present a focused review of 3 key cellular signalling pathways in the injured tubular epithelial cell that have been the focus of much research over the past 2 decades: toll-like receptors, sphingosine-1-phosphate receptors and hypoxia inducible factors. We provide a unique perspective on the potential clinical translations of this recent work in the transplant setting. This is particularly timely with the recent completion of phase I and ongoing phase 2 clinical trials of inhibitors targeting specific components of these signaling cascades.
引用
- Smith SF, Hosgood SA, Nicholson ML, et al. Ischemia-reperfusion injury in renal transplantation: 3 key signaling pathways in tubular epithelial cells. Kidney Int. 2019. PMID: 30606429. doi:10.1016/j.kint.2018.10.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。